Clinical trial
Clinical Outcome of Palliative Surgery After Translational Therapy Versus Maintenance Chemotherapy for Metastatic Gastric Cancer: a Single Center Randomized Controlled Trial
NCT05230771 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcome of Palliative Surgery After Translational Therapy Versus Maintenance Chemotherapy for Metastatic Gastric Cancer: a Single Center Randomized Controlled Trial
- Lead sponsor
- Fujian Medical University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- April 1, 2022
- Completion date
- March 1, 2027
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy, metastatic gastric cancer, surgery